- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT02278172
The Effects of Vitamin D Supplementation on Aerobic Fitness in Athletes (VDAF)
The Effects of Vitamin D Supplementation on VO2max in Athletes: a Randomised, Double-blind, Placebo-controlled Trial
The primary aim of the study is to identify if vitamin D3 supplementation influences VO2max in athletes.
Secondary aims are to determine if vitamin D3 supplementation impacts on measures of muscle function, lung function, body composition, immune function and the self-reported incidence of upper respiratory tract infection.
This double-blind, randomised, placebo-controlled trial is of parallel design and will aim to recruit a total of 50 athletes randomised into either a placebo or treatment group for a 12-week intervention.
Přehled studie
Postavení
Podmínky
Intervence / Léčba
Typ studie
Zápis (Aktuální)
Fáze
- Fáze 4
Kontakty a umístění
Studijní místa
-
-
Londonderry
-
Coleraine, Londonderry, Spojené království, BT52 1SA
- Human Intervention Studies Unit (HISU), University of Ulster
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
- Athletes whose sport does not primarily consist of an anaerobic component
- Apparently healthy
- Over the age of 18
Exclusion Criteria:
- Resting arterial hypertension
- Individuals who are not an athlete at a University/local sports team
- Athletes who predominantly utilise anaerobic energy systems
- Athletes under the age of 18
- Those that have consumed a supplement containing vitamin D (greater than 400IU/day) or iron supplements for up to 30 days prior to starting the study
- Those with health conditions identified by the screening questionnaire
- Individuals that are on prescribed medication that is known to affect vitamin D metabolism
- Those following a vegan diet
- Those with a physical disability that would prevent successful completion of the exercise test
- Those who have either had a sun holiday in the 4 weeks prior to starting the study
- Those planning a sun holiday during the intervention period
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Základní věda
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Trojnásobný
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
---|---|
Aktivní komparátor: Vitamin D3 3000IU (75μg)
Treatment solution delivered via oral spray once daily for 12-weeks
|
3000IU (75 μg) vitamin D in a commercially available oral spray solution
Ostatní jména:
|
Komparátor placeba: Placebo
Placebo solution delivered via oral spray once daily for 12-weeks
|
Placebo oral spray solution manufactured to mimic the vitamin D oral spray
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
---|---|---|
Aerobic fitness (VO2max)
Časové okno: At baseline and at 12-weeks
|
A medical screening questionnaire will be completed prior to the test. Athletes resting blood pressure will be measured twice to rule out resting hypertension. After a standardised warm-up, starting speed will be 8/km/hr at 1% incline, until 17/km/hr, after which incline will increase by 1% every minute until VO2max is met. A metabolic cart (Metalyzer 3B) will measure the athlete's ventilation (oxygen uptake and carbon dioxide output) throughout the test. The test will be terminated when two of the following criterion are met*: Respiratory exchange ratio reaches/exceeds 1.15 AND VO2 plateau observed OR Heart rate within 10bpm of age-predicted maximum * Except when volitional exhaustion occurs Athletes will be asked to refrain from strenuous activity for 24 hours prior to VO2max testing in order to control for last bout effects. Post-exercise lactate concentration (age and gender adjusted) will further-verify that VO2max was attained using a Lactate Pro device. |
At baseline and at 12-weeks
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
---|---|---|
Hand grip strength
Časové okno: At baseline and at 12-weeks
|
Hand grip dynamometry will be used to assess athletes grip strength.
This will be measured on both dominant and non-dominant hands three times.
The athlete will be asked to hold the device and grip as tightly as possible whilst holding the device alongside their body.
There will be a 10 second rest period between measurements.
|
At baseline and at 12-weeks
|
Vertical jump height
Časové okno: At baseline and at 12-weeks
|
Athletes will be asked to reach upwards as far as possible, from a standing position and mark this point on a wall.
After this they will be asked to perform a counter-movement jump a total of 3 times with a 10 second rest-period between jumps, reaching as high as possible and making a mark each time.
Vertical jump height is calculated from the difference between standing reach height and the best height reached when performing a counter-movement jump.
|
At baseline and at 12-weeks
|
Lung function
Časové okno: At baseline and at 12-weeks
|
Forced expiratory volume at 1 second (FEV1) and forced vital capacity (FVC) will be measured. A calibrated Carefusion® MicroLab portable spirometer will be used to measure these variables.The athletes will need to take a maximal inhalation and then perform a full exhalation as fast as possible into a disposable mouthpiece. This procedure will be repeated three times and an average taken at each time-point. The timing of repeats will be at the athletes discretion. |
At baseline and at 12-weeks
|
Nutrient intake
Časové okno: At baseline only/ at baseline and at 12-weeks
|
Dietary vitamin D and calcium intake will be estimated using a validated food frequency questionnaire at one time point (baseline only). This is due to studies highlighting equivocal variation in dietary vitamin D intake throughout the year. 24hr recalls will be completed at baseline and at 12-weeks in order to derive mean nutrient intakes for the vitamin D and placebo treatment groups respectively. |
At baseline only/ at baseline and at 12-weeks
|
Self-reported upper respiratory illness
Časové okno: Once per week up to week 12
|
An online questionnaire will allow athletes to record if they have any symptoms that are associated with upper respiratory infections.
The athlete will be asked to mark a series of boxes to indicate how many symptom(s) if any that they have had each week.
|
Once per week up to week 12
|
Physical activity levels
Časové okno: At baseline and at 12-weeks
|
The 'Modified Recent Physical Activity Questionnaire' produced by the Medical Research Council (a validated physical activity questionnaire) will be completed on two occasions to estimate physical activity levels.
|
At baseline and at 12-weeks
|
Body composition
Časové okno: At baseline and at 12-weeks
|
Body composition will be measured using the BodPod, employing air plethysmography (displacement of air) to accurately measure percentage fat mass and percentage fat-free mass.
|
At baseline and at 12-weeks
|
Vitamin D status
Časové okno: At baseline and at 12-weeks
|
25-hydroxyvitamin D (25(OH)D) will be quantified, in serum, using liquid chromatography-tandem mass spectrometry (LCMS/MS).
Other biomarkers of vitamin D metabolism (adjusted calcium and parathyroid hormone) will be quantified using a clinical chemistry analyser and commercially available enzyme-linked immunosorbent assay.
|
At baseline and at 12-weeks
|
Immune function
Časové okno: At baseline and at 12-weeks
|
A range of immune markers such as interleukin-6, cathelicidin (LL-37) and C-reactive protein will be measured using a commercially available multiplex immunoassay.
|
At baseline and at 12-weeks
|
Spolupracovníci a vyšetřovatelé
Sponzor
Spolupracovníci
Vyšetřovatelé
- Vrchní vyšetřovatel: Pamela J Magee, PhD, University of Ulster
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia
Primární dokončení (Aktuální)
Dokončení studie (Aktuální)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Odhad)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Odhad)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Další relevantní podmínky MeSH
Další identifikační čísla studie
- REC14.0087
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na Aerobic Fitness (VO2max)
-
University of the State of Santa CatarinaDokončeno
-
California State University, San MarcosDokončenoVylepšený VO2max a srdeční výdej v reakci na tréninkSpojené státy
-
Saglik Bilimleri UniversitesiNábor
-
Milton S. Hershey Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)DokončenoSkupinové fitness (tradiční) | Skupinové fitness (založené na hraní her)Spojené státy
-
Josep M CruzadoUkončenoSvalová síla | Porucha související s transplantací ledvin | Cvičení, aerobikŠpanělsko
-
Wilfrid Laurier UniversityNábor
-
University of Texas at AustinDokončenoKardiovaskulární fitnessSpojené státy
-
Riphah International UniversityNáborKardiorespirační fitnessPákistán
-
Duke UniversityNáborKardiorespirační fitnessSpojené státy
-
The University of The West IndiesDokončenoFitness cvičeníJamaica
Klinické studie na Vitamin D
-
Rhode Island HospitalVirtually Better, Inc.DokončenoDuševní zdraví | Virus lidské imunodeficienceSpojené státy
-
Royal Prince Alfred Hospital, Sydney, AustraliaDokončeno
-
GlaxoSmithKlineDokončeno
-
Lee's Pharmaceutical LimitedNeznámýRakovina epitelu vaječníků | Rakovina vejcovodů | Primární peritoneální rakovinaČína
-
Johns Hopkins UniversityNational Institute of Allergy and Infectious Diseases (NIAID)Nábor
-
University of AarhusNovo Nordisk A/S; Aarhus University Hospital; AP Moeller Foundation; Danish Diabetes...NáborStárnutí | Porucha metabolismu | Ketonémie | Svalová poruchaDánsko
-
University Medical Center GroningenMaastricht University Medical Center; UMC Utrecht; Academisch Medisch Centrum... a další spolupracovníciDokončeno
-
Daewoong Pharmaceutical Co. LTD.Zatím nenabíráme
-
Brigham and Women's HospitalDokončeno
-
Abbott Medical DevicesDokončeno